Revisiting the use of capecitabine in the era of immunotherapy: Efficacy as second-line and later therapy in recurrent/metastatic head and neck squamous cell carcinoma.
Saved in:
| Title: | Revisiting the use of capecitabine in the era of immunotherapy: Efficacy as second-line and later therapy in recurrent/metastatic head and neck squamous cell carcinoma. |
|---|---|
| Authors: | Ma J; Department of Pharmacy, University of North Carolina Medical Center, 101 Manning Drive, Chapel Hill, NC 27514, USA. Electronic address: joannacma1@gmail.com., Brooks C; Department of Pharmacy, University of North Carolina Medical Center, 101 Manning Drive, Chapel Hill, NC 27514, USA., Tasoulas J; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Wind LS; Department of Pharmacy, University of North Carolina Medical Center, 101 Manning Drive, Chapel Hill, NC 27514, USA., Sheth S; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA; Department of Medicine, Division of Oncology, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Gwynn M; Department of Pharmacy, University of North Carolina Medical Center, 101 Manning Drive, Chapel Hill, NC 27514, USA. |
| Source: | Oral oncology [Oral Oncol] 2025 May; Vol. 164, pp. 107293. Date of Electronic Publication: 2025 Apr 10. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
